Variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have emerged continuously, challenging the effectiveness of vaccines, diagnostics, and treatments. Moreover, the possibility of the appearance of a new betacoronavirus with high transmissibility and high fatality is reason for concern. In this study, we used a natively paired yeast display technology, combined with next ...Introduction. Immunoglobulin (IVIG) is approved as a therapeutic for chronic autoimmune and inflammatory processes such as immune thrombocytopenia purpura (ITP) and Kawasaki disease, among others ( 1 ). However, IVIG is expensive to produce, has blood borne pathogen risks, toxic side effects, and because it is pooled from plasma from …Keynote Speaker Brandon DeKosky, PhD Professor of Chemical Engineering, Massachusetts Institute of Technology (MIT) His research group contributes to the incredible expansion in quantitative biotechnology and drug development, making discoveries in an exciting field that continues to evolve.andrew p davison. UMR9197 Institut des Neurosciences Paris Saclay (Neuro-PSI) Gif-sur-Yvette, France. Associate Editor. Integrative Systems Neuroscience.Brandon Dekosky Professor, Chemical Engineering More efficient antibody discovery against viruses and membrane protein targets. Impact: New membrane protein targets and creation of new medicines. TLO Case #: 23890 Betar Gallant Professor, Mechanical Engineering Development of a new hybrid solid-liquid cathode. Impact: increased energy of ...The University of Kansas is a public institution governed by the Kansas Board of Regents.Brandon DeKoskyMIT, Boston, US. Gerhard KronkeUniversity Hospital Erlangen, DE. Laurent ReberINFINITy Institute INSERM, Toulouse, FR. Lubka RoumeninaINSERM ...4.2.1 VH:VL Gene Usage Across B Cell Subsets. We analyzed the peripheral blood antibody repertoire of three human donors using the single B cell VH:VL sequencing technique reported and described in Chapter Four [].We would like to show you a description here but the site won’t allow us.The AIRR Community Guide to Quality Control: Chain Pairing Precision and Monitoring of Cross-Sample Contamination. Chung C-Y, Gutiérrez-González M, López Acevedo SN, Fahad AS, DeKosky BJ. Immunogenetics: Methods and Protocols, Methods in Molecular Biology, y, (Springer Nature) ISBN: 9781071621141 , 2022. Antibodies Computational immunology ..."Whenever he's looking at taking on a new project, he does this check to see if it's worthwhile and if somebody would want to use it," says Brandon DeKosky, one of Georgiou's graduate research assistants. "That's the driving force behind why so much of his work gets out there — he makes sure whatever he's working on is going to be useful."Dr. Brandon Dekosky Date Defended: 12/5/19 . i The Thesis Committee for Allison J. Brachtenbach certifies that this is the approved version of the following thesis: Characterization of MSY Nanodiamonds as a Nanoparticulate Adjuvant for RiVax Vaccine _____ Chairperson: Dr. M. Laird Forrest ...We are delighted to announce that the Board of Directors has selected Dr. Brandon DeKosky as the 2022 James S. Huston Antibody Science Talent Award… Liked by Emily CoatesNew antibodies against malaria Highly protective anti-malarial antibodies via precision yeast display library generation and screening. Banach BB, Tripathi P, Pereira L, Gorman J, Nguyen TD, Dillon M, Fahad AS, Kiyuka P, Madan B, Wolfe JR, Bonilla B, Flynn B, Francica JR, Hurlburt NK, Liu T, Ou L, Rawi R, Schön A, Shen C-H, Teng I-T, Zhang B, Pancera M, Idris AH, Seder RA, Kwong PD, DeKosky BBrandon J. DeKosky Yariv Wine Monoclonal antibodies (mAbs) are a crucial asset for human health and modern medicine, however, the repeated administration of mAbs can be highly immunogenic.Brandon DeKosky - Associate Professor of Chemical Engineering - Massachusetts Institute of Technology | LinkedIn Brandon DeKosky Associate Professor at MIT and The Ragon Institute/MGH...Oct 4, 2023 · James (Jim) S. Huston, Ph.D., (1945-2020) was a pioneering and visionary antibody engineer; his invention of the single chain Fv (sFv or scFv) antibody was a seminal advance. These genetically encoded molecules could express the vast diversity of antibody repertoires, be used for specific target binding by themselves, incorporated into multifunctional molecules, attached to cell […] Brandon DeKosky is an assistant professor at the Departments of Pharmaceutical Chemistry, Chemical & Petroleum Engineering, and the Kansas Vaccine Institute at the University of Kansas. Dr. DeKosky attained his Ph.D. in the lab of George Georgiou at the University of Texas at Austin where he developed new technologies for sequencing complete ...Brandon DeKosky. Doctoral Fellow Chemical Engineering Previous degree from University of Kansas UT Austin: Department of Chemical Engineering Brandon is investigating the gene expression of antibody-secreting B-cells toward the creation of new antibody therapeutics. He is most interested in studying the genetic recombination that gives rise to ...Brandon DeKosky, PhD, Assistant Professor, The University of Kansas "Extremely high-quality presentations and excellent networking opportunities. Feedback from the FDA was invaluable"Katie Galloway is the W. M. Keck Career Development Professor in Biomedical Engineering and Chemical Engineering at Massachusetts Institute of Technology (MIT). Her research focuses on elucidating the fundamental principles of integrating synthetic circuitry to drive cellular behaviors. Her lab focuses on developing integrated gene circuits and ...KU faculty members mentor students around the world.Harvard-MIT Health Sciences and Technology (HST) Jun 2022 - Present1 year 5 months. Cambridge, Massachusetts, United States. Rotated in Jonathan Weissman lab (Whitehead Institute); Brandon DeKosky ...The 2009 nominees for KU are: Brandon DeKosky, Overland Park; Rebecca Marie Getman, from Chesterfield, Mo.; Christopher Blake Martin, from Manhattan; and Richard Z. Robinson, from Garnett ...Brandon DeKosky Massachusetts Institute of Technology; The Ragon Institute Verified email at mit.edu. Follow. Wei Jin. Postdoctoral Researcher in The University of Kansas. Verified email at ku.edu. Pharmaceutical science. Articles Cited by Public access Co-authors. Title. Sort. Sort by citations Sort by year Sort by title.Nguyen Bui, Vietnam, Ho Chi Minh City, Creighton University; "Rapid Antibody Library Construction of VRC34 by Nicking Site Saturation Mutagenesis," Brandon DeKosky and Thuy-Duong Nguyen, pharmaceutical chemistry.250 First Avenue, Suite 300 Needham, MA 02494 P: 781.972.5400 F: 781.972.5425 E: [email protected] DEKOSKY | Assistant Professor | PhD | University of Kansas, Kansas | KU | Chemical Engineering & Pharmaceutical Chemistry | Research profile Brandon DEKOSKY, Assistant Professor | Cited...Brandon Dekosky, Kansas University Shohei Koide, New York University. Stefan Stahl, Royal Swedish Institute (KTH) Birgit Dreier, University of Zurich Mary Ann Pohl, Tri-Institutional Therapeutics Discovery Institute . This course is supported with funds provided by: National Institute of General Medical Sciences.The Insider Trading Activity of Buhler Brandon B on Markets Insider. Indices Commodities Currencies StocksBrandon DeKosky Phillip and Susan Ragon Career Development Professor of Chemical Engineering email [email protected] room 400 Technology Square, Room #1020 Research Website Support Staff Alina HavertyJanine Schuurman posted images on LinkedInDepartment of Chemical Engineering. Massachusetts Institute of Technology. 25 Ames Street, Building 66. Cambridge, MA 02139, USA. tel: 617.253.4561. fax: 617.258.8992. If you would like more information about Chemical Engineering at MIT or have any questions, comment or suggestions about the ChemE website, please fill out the form below. Name ..."Whenever he's looking at taking on a new project, he does this check to see if it's worthwhile and if somebody would want to use it," says Brandon DeKosky, one of Georgiou's graduate research assistants. "That's the driving force behind why so much of his work gets out there — he makes sure whatever he's working on is going to be useful."Florida State University. FSU | College of Medicine. Contacts; Search FSU COM; NavigationComprehensive molecular and functional analyses of anti-HIV-1 broadly neutralizing antibody repertoires Dekosky, Brandon JamesAug 8, 2020 · Library sequences were quality-filtered for a Q-score of 30% for over 90% of the raw read using fastxtoolkit (DeKosky, Kojima et al. 2015, McDaniel, DeKosky et al. 2016). Open reading frames were identified and translated into amino acid sequences, and usearch (v5.2.6) was used to identify different Fc genes ( Edgar 2010 ). 2010. Ultra-high-throughput sequencing of the immune receptor repertoire from millions of lymphocytes. JR McDaniel, BJ DeKosky, H Tanno, AD Ellington, G Georgiou. Nature protocols 11 (3), 429-442. , 2016. 148. 2016. Functional interrogation and mining of natively paired human V H :V L antibody repertoires.Home About Select to follow link Contact Events Select to follow link Haslam Special Topics in Formulation Series 2023Brandon Dekosky, Kansas University Shohei Koide, New York University. Stefan Stahl, Royal Swedish Institute (KTH) Birgit Dreier, University of Zurich Mary Ann Pohl, Tri-Institutional Therapeutics Discovery Institute . This course is supported with funds provided by: National Institute of General Medical Sciences.Nov 9, 2022 · DeKosky BJ, Ippolito GC, Deschner RP, Lavinder JJ, Wine Y, Rawlings BM, Varadarajan N, Giesecke C, Dörner T, Andrews SF, Wilson PC, Hunicke-Smith SP, Willson CG, Ellington AD, Georgiou G (2013) High-throughput sequencing of the paired human immunoglobulin heavy and light chain repertoire. Our interviewer Brandon DeKosky of Massachusetts Institute of Technology welcomes… Please have a listen to this new episode of The Chain podcast. Liked by Olga M. PaleyHome About Select to follow link Contact Events Select to follow link Calendar Mossberg SymposiumThe new screen works by focusing on two specific regions of the antibody - the VH and the LH [1] — as author Brandon DeKosky explains: "Antibody molecules are encoded by B cells and are assembled from two different genes, called the heavy and light chains. The VH and VL portions - derived from the heavy and light chains, respectively ...Bo Wang 1 , Brandon J DeKosky 2 3 4 , Morgan R Timm 2 , Jiwon Lee 1 , Erica Normandin 2 , John Misasi 2 , Rui Kong 2 , Jonathan R McDaniel 1 , George Delidakis 1 , Kendra E Leigh 2 , Thomas Niezold 2 , Chang W Choi 2 , Elise G Viox 2 , Ahmed Fahad 4 , Alberto Cagigi 2 , Aurélie Ploquin 2 , Kwanyee Leung 2 , Eun Sung Yang 2 , Wing-Pui Kong 2 ...Comprehensive molecular and functional analyses of anti-HIV-1 broadly neutralizing antibody repertoires Dekosky, Brandon JamesBrandon DeKosky, PhD. Massachusetts General Hospital. High-throughput Functional Screening of Personalized anti-cancer T cell Receptor Repertoires. Research Scholar Grant . Immune-based therapies and CD8+ T cells can effectively control cancer progression for many patients. However, technical barriers in T cell receptor (TCR) analysis have ...Our interviewer Brandon DeKosky of Massachusetts Institute of Technology welcomes… Please have a listen to this new episode of The Chain podcast. Liked by Olga M. PaleyThis project will develop a new technological approach for the comprehensive analysis of adaptive immune responses, which holds the potential to catalyze new strategies to prevent and treat disease. H...Dr. Brandon DeKosky Lab, University of Kansas—Department of Pharmaceutical Chemistry (Lawrence, KS) • Optimized a PCR-based site-directed mutagenesis method for rapidly and effectively mutating antibody sequences. o Designed mutagenic primers and introduced site-directed mutations into antibody36 Massachusetts General Hospital Mgh Postdoctoral jobs available on Indeed.com. Apply to Research Fellow, Post-doctoral Fellow and more!Brandon DeKosky Associate Professor at MIT and The Ragon Institute/MGH Cambridge, MA. Connect Karmel S. Shehadeh Assistant Professor of Industrial and Systems Engineering--Lehigh University at ...Brandon DeKosky, Ph.D., University of Kansas: Molecular analysis of antibody responses associated with COVID-19 respiratory distress; Marta Maria Gaglia, Ph.D., Tufts University: Control of innate immune responses by SARS-CoV-2;Immunoglobulin/T Cell Receptor Capture Strategy for Comprehensive Immunogenetics. James Peter Stewart, Jana Gazdova, Shambhavi Srivastava, Julia Revolta, Louise Harewood, Manisha Maurya, Nikos Darzentas, and David Gonzalez. Published online: May 28, 2022. 1.Brandon J. DeKosky, Assistant Professor, The University of Kansas , Lawrence, K S 9:40 AM to 10:10 AM Lessons Learned from the MHC II Immunopeptidome Laura Santambrogio, MD, PhD, Professor of Pathology, Immunology and Microbiology Albert Einstein College of Medicine, New York, NY BREAK 10:10 AM to 10:25 AMEurope PMC is an archive of life sciences journal literature.Festival of Biologics USA Agenda 2024. Our agenda is expertly curated by an experienced team of producers with an expansive global network. The Festival of Biologics is your opportunity to hear from industry leaders, global regulators and world-renowned academics at the forefront of innovation. Join us for 3 days of cutting-edge insights into ...Dr. Brandon DeKosky is an assistant professor of Chemical Engineering and Pharmaceutical Chemistry and affiliated with the Kansas Vaccine Institute at the University of Kansas, and his research emphasis is in high-throughput analyses of antibody immune responses.Monoclonal antibodies (mAbs) are an important class of therapeutics used to treat cancer, inflammation, and infectious diseases. Identifying highly developable mAb sequences in silico could greatly reduce the time and cost required for therapeutic mAb development. Here, we present position-specific scoring matrices (PSSMs) for antibody …This RAI ICC2 project targets border areas of Cambodia and Thailand to: map hotspots of infection and identify subpopulations with the highest risk of infection as well as under-utilisation of current malaria control methods;Europe PMC is an archive of life sciences journal literature.Graduate students who participate (left to right): Apollo Stacy, Dr. Greg Clark, Aimee Wessel, Inga Jarmoskaite, Brandon DeKosky, Peter Enyeart, Josh Russell, Marisa Miller, Gabriel Wu, Stephanie Taylor, Damon Polioudakis and Brant Gracia.A new technology can screen orders of magnitude more antibodies than existing methods. Elly Earls finds out why this breakthrough could vastly improve our understanding of how to leverage the immune system to prevent and cure disease Elly Earls Brandon DeKosky Elly Earls Brandon DeKosky Elly Earls Brandon DeKosky Elly Earls Brandon DeKosky Elly Earls Brandon DeKosky Elly Earls Brandon DeKosky ...Cambridge Healthtech Institute PodcastsBrandon J DeKosky Present address: Present address: Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.,Human antibody responses are established by the generation of combinatorial sequence diversity in antibody variable domains, followed by iterative rounds of mutation and selection via T cell ...Brandon Dekosky Professor, Chemical Engineering More efficient antibody discovery against viruses and membrane protein targets. Impact: New membrane protein targets and creation of new medicines. TLO Case #: 23890 Betar Gallant Professor, Mechanical Engineering Development of a new hybrid solid-liquid cathode. Impact: increased energy of ...Brandon J. DeKosky Yariv Wine Monoclonal antibodies (mAbs) are a crucial asset for human health and modern medicine, however, the repeated administration of mAbs can be highly immunogenic.Brandon DeKosky. Phillip and Susan Ragon Career Development Professor of Chemical Engineering. Patrick S. Doyle. Robert T. Haslam (1911) Professor of Chemical Engineering, Singapore Research Professor. Lawrence B. Evans. Professor Emeritus. Ariel L. Furst Paul M. Cook Career Development Professor ...Brandon DeKosky (center left) and graduate student trainees Rukmini Ladi, Bailey Banach, and Ahmed Fahad (from left).Brandon DeKosky. A research lab at the University of Kansas School of Engineering and School of Pharmacy led by Brandon DeKosky is analyzing the genetics of human immune responses to develop the basis of an effective vaccine or drug therapy against Epstein-Barr Virus, or EBV, the pathogen that causes mono and infects around 90-percent of adults worldwide.1.11.2020 г. ... Brandon Dekosky, at the University of Kansas, and Dr. Tom Geisbert laboratory and University of Texas Medical Branch (UTMB) receive a ...12.10.2022 г. ... This research will provide important insights into new treatment targets and approaches. Brandon DeKosky, PhD. Massachusetts General Hospital.Cambridge Healthtech Institute PodcastsMar 23, 2022 · Correspondence to Brandon J. DeKosky: [email protected] Peter D. Kwong: [email protected] Disclosures: B.B. Banach reported a patent for neutralizing antibodies to Plasmodium falciparum circumsporozoite protein and their use pending (attorney ref. no. 4239-107438-01). Brandon DeKosky is an assistant professor at the Departments of Pharmaceutical Chemistry, Chemical & Petroleum Engineering, and the Kansas Vaccine Institute at the University of Kansas. Dr. DeKosky attained his Ph.D. in the lab of George Georgiou at the University of Texas at Austin where he developed new technologies for sequencing complete ... Brandon DeKosky. Nathan Dormer. William Gilbert. Patricia A. Huber. Anisha Patel. Joseph Lomakin. 2009 Annual Meeting. Associated proceedings: 2009 Annual Meeting. Access to contact information is restricted to users who have purchased the conference's Online Proceedings, or received access to the proceedings as part of the conference Registration.Department of Chemical Engineering. Massachusetts Institute of Technology. 25 Ames Street, Building 66. Cambridge, MA 02139, USA. tel: 617.253.4561. fax: 617.258.8992. If you would like more information about Chemical Engineering at MIT or have any questions, comment or suggestions about the ChemE website, please fill out the form below. Name ...The Batista and DeKosky labs also have appointments with Harvard and MIT, respectively. This position is ideal for individuals who are interested in launching a career as biomedical research leaders in either academia or industry. ... Dr. Brandon DeKosky at [email protected] . Author:Brandon DeKosky of the Department of Chemical Engineering received the Antibody Society's James S. Huston Antibody Science Talent Award on Oct. 20. Lee Gehrke of the Institute for Medical Engineering and Science was named a 2022 National Academy of Inventors Fellow on Dec. 8.Brandon DeKosky Associate Professor at MIT and The Ragon Institute/MGH Cambridge, MA. Jamie Baggett CFO, MPA, NREMT-P Deputy Fire Chief Greater Fayetteville, AR Area ...A new song by Bryson Gray called "Let's Go Brandon," one of multiple musical tributes to the anti-Biden meme, also bumped Adele's new hit, "Easy On Me," out of the top spot on iTunes ...There's a high chance you know someone whose life has been saved, extended or improved by a drug invented by University of Kansas professor ValentinoBrandon DeKosky Massachusetts Institute of Technology; The Ragon Institute Verified email at mit.edu. ... BJ DeKosky, NH Dormer, GC Ingavle, CH Roatch, J Lomakin, ... Tissue Engineering Part C: Methods 16 (6), 1533-1542, 2010. 170: 2010: Mass transfer in pH-sensitive hydrogels.Seminar Series. During the academic year, Georgia Tech's School of Chemical & Biomolecular Engineering hosts regular research seminars, in which distinguished researchers are invited to speak about their work. The Ashton Hall Cary and Freeman H. Cary Lectureship. Phillips 66 / C.J. "Pete" Silas Program in Ethics and Leadership.Brandon DeKosky, Assistant Professor of Chemical Engineering, MIT (CONFIRMED) 10:40am Networking Break 11:30am Round Table Sessions There will be one rotation, each 30 minutes with 5 minutes to change over TABLE 1 Multispecific antibodies: challenges & analytical strategies Jonathan Davis, VP of Innovation and Strategy, Invenra …Brandon J Dekosky. Departments of Chemical. Engineering and Pharmaceutical. Chemistry, The University of. Kansas, Lawrence, KS 66045, USA. Deadline for ...This project will develop a new technological approach for the comprehensive analysis of adaptive immune responses, which holds the potential to catalyze new strategies to prevent and treat disease. H...
Festival of Biologics USA Agenda 2024. Our agenda is expertly curated by an experienced team of producers with an expansive global network. The Festival of Biologics is your opportunity to hear from industry leaders, global regulators and world-renowned academics at the forefront of innovation. Join us for 3 days of cutting-edge insights into .... Nike celso womens
76 undergraduate students to present summer research. Wed, 07/25/2018. LAWRENCE — Each summer, undergraduate students from around the world join current University of Kansas students in conducting research with KU faculty. Seventy-six of these students will present their research Friday, July 27 , at the KU Summer Undergraduate Research ...Brandon Dekosky, Kansas University Shohei Koide, New York University. Stefan Stahl, Royal Swedish Institute (KTH) Birgit Dreier, University of Zurich Mary Ann Pohl, Tri-Institutional Therapeutics Discovery Institute . This course is supported with funds provided by: National Institute of General Medical Sciences.Brandon DeKosky Department of Chemical Engineering, University of Texas at Austin, Austin, TX 78731, USA. Present address: Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.Brandon DeKosky Research Interests biotechnology, vaccines, molecular immunology, single cell analysis, antibodies, t cell receptors, immune biomaterials, protein drug developmentBrandon DeKosky Associate Professor at MIT and The Ragon Institute/MGH Cambridge, MA. Jamie Baggett CFO, MPA, NREMT-P Deputy Fire Chief Greater Fayetteville, AR Area ...The whole content of this chapter was initially published in DeKosky, B.J. et al. High-throughput sequencing of the paired human immunoglobulin heavy and light chain repertoire. Nat. Biotechnol. 31, 166–169 (2013), and it is reproduced here. B.J.D. and G.G. developed the methodology and designed the experiments.Bo Wang 1 , Brandon J DeKosky 2 3 4 , Morgan R Timm 2 , Jiwon Lee 1 , Erica Normandin 2 , John Misasi 2 , Rui Kong 2 , Jonathan R McDaniel 1 , George Delidakis 1 , Kendra E Leigh 2 , Thomas Niezold 2 , Chang W Choi 2 , Elise G Viox 2 , Ahmed Fahad 4 , Alberto Cagigi 2 , Aurélie Ploquin 2 , Kwanyee Leung 2 , Eun Sung Yang 2 , Wing-Pui Kong 2 ... Brandon J. DeKosky joined the Department of Chemical Engineering as an assistant professor in a newly introduced joint faculty position between the department and the Ragon Institute of MGH, MIT and Harvard in September 2021. Home About Select to follow link Contact Events Select to follow link Haslam Special Topics in Formulation Series 2023At the Society's Antibody Engineering & Therapeutics booth with Prof. Brandon DeKosky, 2022 Huston Award winner! Liked by Jihwan Chun. Meet Hafcha from the rise program! Learn about RISE: https ...Department of Chemical Engineering 77 Massachusetts Avenue, Room 66-350 Cambridge, Massachusetts 02139Brandon DeKosky . CONTRACTING ORGANIZATION: The University of Kansas Center for Research, Inc. REPORT DATE: August 2021 . TYPE OF REPORT: Annual Report . PREPARED FOR: U.S. Army Medical Research and Materiel Command ... E-Mail: [email protected] 7. PERFORMING ORGANIZATION NAME(S) AND ADDRESS(ES) 5f. WORK UNIT NUMBER: 8. PERFORMING ORGANIZATION REPORTDeKosky BJ, Lungu OI, Park D, Johnson EL, Charab W, Chrysostomou C, et al.. Large-Scale Sequence and Structural Comparisons of Human Naive and Antigen-Experienced Antibody Repertoires. Proc Natl Acad Sci USA (2016) 113 (19):E2636–45. 10.1073/pnas.1525510113 [PMC free article] [Google Scholar]Congratulations to KI members Michael Birnbaum, Ömer Yilmaz, Brandon DeKosky and Regina Barzilay, along with their MIT colleague Seychelle Vos, on… Liked by Yuyan Cai7.05.2010 г. ... ... Brandon DeKosky, Glen Marotz, Stuart Bell and KU Chancellor Bernadette Gray-Little. The new building will house laboratories for ...Apr 1, 2010 · Home About Select to follow link Visit Us Our Mission Outreach and Events Brandon DeKosky (Kansas University; Single-cell/B-cell) Nina LuningPrak (member of the WG; UPenn; MRD; control sample) Chris Tipton (member of the WG; Emory) Johannes Trueck (member of the WG; Synthetic IgG) Encarnita Mariotti-Ferrandiz (member of the WG; T cell repertoire/autoimmune disease)Matheus is a fifth year PhD candidate at The University of Kansas, and the Ragon Institute of MGH, MIT, and Harvard. As a graduate research assistant at Dr. Brandon DeKosky's laboratory, Matheus' research focuses on the application of novel technologies, such as yeast display and next generation sequencing, for understanding humoral immune responses to infectious diseases.Although a cure for HIV continues to elude scientists, strategies to control the virus and immunise people are developing at rapid pace. Here, Drug Target Review's Victoria Rees discusses why researchers are focusing on antibodies as approaches to combat HIV and highlights recent findings from two pre-clinical studies into how antibodies can be used as treatments and prophylactics for the virus..